Similar Stories to Forget Tilray, These Two Biotech Stocks Have Far More Upside on Bing News

Canada's Tilray (NASDAQ: TLRY), a marijuana cultivator and distributor, has given early investors the ride of their lives since going public last June. Last week, for instance, the company's stock peaked at exactly $300 per share, representing a jaw-dropping 856% gain for the brave souls that bought this speculative IPO right off the bat. Even though Tilray's shares have pulled back in a big way since reaching this gravity-defying peak a few days ago, the pot grower's valuation remains wildly disconnected from its near-term growth prospects.

Topics:  canada's tilray nasdaq   tlry    june   ipo   tilray   images   growth   investors   
BING NEWS:
  • Tilray Brands Inc.
    Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
    06/17/2024 - 3:56 pm | View Link
  • Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts
    Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.69, moving -0.59% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.77%. On the ...
    06/17/2024 - 11:00 am | View Link
  • 7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
    Biotech stocks operate under a core ethos. While there’s been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing is ...
    06/17/2024 - 8:27 am | View Link
  • Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
    Biotech stocks are always interesting from a trading perspective. With dozens of companies in the clinical-stage, positive news from trials can be a big catalyst for a scintillating rally. Biotech ...
    06/10/2024 - 6:22 am | View Link
  • 3 Biotech Stocks to Monitor Right Now
    Vaccine stocks make up a healthy portion of biotech exchange-traded fund XBI NVAX is down 12.4% to trade at $15.91 today, with no specific catalyst to explain the gap lower, and on track for its worst ...
    06/10/2024 - 4:33 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News